Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PHAT compared with NAMS: revenue, margins and what each company keeps, and the suppliers and customers both name
PHAT
Phathom Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PHAT
Phathom Pharmaceuticals, Inc.
vs
NAMS
NewAmsterdam Pharma Co N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
PHAT
with
NAMS
No shared trading history for PHAT and NAMS.
Shared co-movers: not yet measured (NAMS).
PHAT, solid
NAMS, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
PHAT
Phathom Pharmaceuticals, Inc.
Change
5.73
▼
−7.88%
· post 5.85
Mkt cap
$466.6M
Revenue
$85M
Q3 FY26
Revenue
$175M
FY25
NAMS
NewAmsterdam Pharma Co N.V.
Change
20.05
▼
−3.42%
· post 20.05
Closed
Oct 30 '26
Mkt cap
$2.4B
Revenue
$4M
Q2 FY26
Revenue
$23M
FY25
vs
Compare
Closed
Oct 30 '26
PHAT
Phathom Pharmaceuticals, Inc.
vs
NAMS
NewAmsterdam Pharma Co N.V.
5.73
▼
−7.88%
post 5.85
Price
20.05
▼
−3.42%
post 20.05
$466.6M
Mkt cap
$2.4B
Q3 FY26
$85M
Revenue
$4M
Q2 FY26
FY25
$175M
Revenue
$23M
FY25
Change
Change
PHAT
5.73
▼
−7.88%
vs
NAMS
20.05
▼
−3.42%
Closed
Oct 30 '26